The following table contains data from a study on the survival times T (in days) of
eighteen patients with lung diseases. Right censored observations are denoted by “+”.
Days to death
8 8 26+ 29 69 76+ 77 78+ 79 108 115 122+ 153 154 157+ 180+ 190+
211+
(a) Estimate the survival function S(t) using the Kaplan-Meier estimator. Compute the standard error of the estimate at each of the uncensored time points.
(b) Estimate the median and the 25th-percentile of the survival time based on the Kaplan-Meier estimates.
(c) Construct a 95% confidence interval for S(t) at t = 100 days.
(d) Based on the Epanechnikov kernel function given by K(u) = 0.75(1 − u2) for−1 ≤ u ≤ 1 with a bandwidth of h = 30, estimate λ(100) with a pointwise 95% confidence interval.
(e) Assume that T can be modeled by an exponential distribution with density functionf(t) = λexp(−λt), for t,λ > 0.
i. Find the maximum likelihood estimate for λ.
ii. Estimate the mean of T and P(T > 100). Give a point estimate
and a 95% confidence interval for each case.
time=c(8,8,26,29,69,76,77,78,79,108,115,122,153,154,157,180,190,211);time
length(time)
satus=c(1,1,0,1,1,0,1,0,1,1,1,0,1,1,0,0,0,0);satus
length(satus)
ctc=data.frame(time,satus);ctc
plot(surv.bygr,conf.int=F,xlab="time",ylab="survival
function",cex=0.6)
The following table contains data from a study on the survival times T (in days) of...
Identify the scientific premise, main hypothesis addressed by the paper and the research question of the paper Also, what is the main results and the implication of results IMPORTANCE Clinical outcomes for glioblastoma remain poor. Treatment with immune checkpoint blockade has shown benefits in many cancer types. To our knowledge, data from a randomized phase 3 clinical trial evaluating a programmed death-1 (PD-1) inhibitor therapy for glioblastoma have not been reported. OBJECTIVE To determine whether single-agent PD-1 blockade with nivolumab...